Okogen
TX - PlanoBiotechnology
Focus: Okogen is a public biotechnology company founded in 2013 and headquartered in Plano, TX, specializing in pink eye treatment. The company operates as a focused biotech player in the ophthalmology space.
Profile data last refreshed 22h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
0
About Okogen
AI assessmentNot HiringNo open roles listed right now. Follow Okogen to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
OKG-0301
Adenoviral ConjunctivitisClinical Trials (1)
NCT03856645OKG-0301 for the Treatment of Acute Adenoviral Conjunctivitis
Phase 2Help build intelligence for Okogen
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.